Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification

Human Molecular Genetics

Volumn 13, Issue REV. ISS. 1, 2004, Pages

  McCarthy, Mark I ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; SULFONYLUREA DERIVATIVE;

ADULTHOOD; CHILDHOOD; DIAGNOSTIC PROCEDURE; DISEASE PREDISPOSITION; DRUG MECHANISM; DRUG TARGETING; ENVIRONMENTAL FACTOR; GENE IDENTIFICATION; GENE INTERACTION; GENE REPLICATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEALTH CARE DELIVERY; HUMAN; JUVENILE DIABETES MELLITUS; MATURITY ONSET DIABETES MELLITUS; MEDICAL INFORMATION; MOLECULAR CLONING; MONOGENIC DISORDER; MOUSE; MULTIFACTORIAL GENETIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PATIENT CARE; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; REVIEW; RISK ASSESSMENT;

DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MULTIFACTORIAL INHERITANCE; SYNDROME;

EID: 1842526874     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (124)

1. Zimmet, P., Alberti, K.G.M.M. and Shaw, J. (2001) Global and societal implications of the diabetes epidemic. Nature, 414, 782-787.
2. Perry, R. and Baron, A. (1999) Impaired glucose tolerance. Why is it not a disease? Diabetes Care, 22, 920-924.
3. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837-853.
4. Tuomilehto, J., Lindstrom, J., Eriksson, J.G., Valle, T.T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M. et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New Engl. J. Med., 344, 1343-1350.
5. Bell, G.I. and Polonsky, K.S. (2001) Diabetes mellitus and genetically programmed defects in β-cell function. Nature, 414, 788-791.
6. Saltiel, A.R. and Kahn, C.R. (2002) Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 414, 799-806.
7. Frayn, K.N. (2001) Adipose tissue and the insulin resistance syndrome. Proc. Nut. Soc., 60, 375-380.
8. Hitman, G.A. and McCarthy, M.I. (1991) Genetics of non-insulin dependent diabetes mellitus. Bailliere's Clin. Endocrinol. Metab., 5, 455-476.
9. Ozanne, S.E. and Hales, C.N. (1998) Thrifty yes, genetic no. Diabetologia, 41, 485-487.
10. Ozanne, S.E. (2001) Metabolic programming in animals. Br. Med. Bull., 60, 143-152.
11. Ravelli, A.C.J., van der Meulen, J.H.P., Michels, R.P.J., Osmond, C., Barker, D.J.P., Hales, C.N. and Bleker, O.P. (1998) Glucose tolerance in adults after prenatal exposure to famine. Lancet, 351, 173-177.
12. Poulsen, P., Vaag, A.A., Kyvik, K.O., Møller Jensen, D. and Beck-Nielsen, H. (1997) Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia, 40, 439-446.
13. Kramer, M.S. and Joseph, K.S. (1996) Enigma of fetal/infant-origins hypothesis. Lancet, 348, 1254-1255.
14. McCarthy, M.I. (1998) Weighing in on diabetes risk. Nat. Genet., 19, 209-210.
15. Hattersley, A.T. and Tooke, J.E. (1999) The fetal insulin hypothesis an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet, 353, 1789-1792.
16. Hattersley, A.T., Beards, F., Ballantyne, E., Appleton, M., Harvey, R. and Ellard, S. (1998). Mutations in the glucokinase gene of the foetus result in reduced birth weight. Nat. Genet., 19, 268-270.
17. Dunger, D.B., Ong, K.K.L., Huxtable, S.J., Sherriff, A., Woods, K.A., Ahmed, M.L., Golding, J., Pembrey, M.E., Ring, S. et al. (1998) Association of the INS VNTR with size at birth. Nat. Genet., 19, 98-100.
18. Hypönnen, E., Davey Smith, G. and Power, C. (2003) Parental diabetes and birth weight of offspring: Intergenerational cohort study. Br. Med. J., 326, 19-20.
19. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997). Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 20, 1183-1197.
20. McCarthy, M.I. and Hattersley, A.T. (2001) Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes. Expert Rev. Mol. Diagn., 1, 403-412.
21. Owen, K. and Hattersley, A.T. (2001) Maturity-onset diabetes of the young: From clinical description to molecular genetic characterization. Best Pract. Res. Clin. Endocrinol. Metab., 15, 309-323.
22. Fajans, S. (1990) Scope and heterogeneous nature of MODY. Diabetes Care, 13, 49-64.
23. Froguel, P., Vaxillaire, M., Sun, F., Velho, G., Zouali, H., Butel, M.O., Lesage, S., Vionnet, N., Clément, K., Fougerousse, F. et al. (1992) Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature, 356, 162-165.
24. Hattersley, A.T., Turner, R.C., Permutt, M.A., Patel, P., Tanizawa, Y., Chiu, K.C., O'Rahilly, S., Watkins, P.J. and Wainscoat, J.S. (1992) Linkage of type 2 diabetes to the glucokinase gene. Lancet, 339, 1307-1310.
25. Yamagata, K., Oda, N., Kaisaki, P.J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R.D., Lathrop, G.M., Boriraj, V.V. et al. (1996) Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature, 384, 455-458.
26. Yamagata, K., Furuta, H., Oda, N., Kaisaki, P.J., Menzel, S., Cox, N.J., Fajans, S.S., Signorini, S., Stoffel, M. and Bell, G.I. (1996) Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature, 384, 458-460.
27. Horikawa, Y., Iwasaki, N., Hara, M., Furuta, H., Hinokio, Y., Cockburn, B.N., Lindner, T., Yamagata, K., Ogata, M., Tomonaga, O. et al. (1997) Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with MODY. Nat. Genet., 17, 384-385.
28. Stoffers, D.A., Ferrer, J., Clarke, W.L. and Habener, J.F. (1997) Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat. Genet., 17, 138-139.
29. Malecki, M.T., Jhala, U.S., Antonellis, A., Fields, L., Doria, A., Orban, T., Saad, M., Warram, J.H., Montminy, M. and Krolewski, A.S. (1999) Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat. Genet., 23, 323-328.
30. Matschinsky, F.M. (1990) Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes, 39, 647-652.
31. Ahlgren, U., Jonsson, J., Jonsson, L., Simu, K. and Edlund, H. (1998) Beta-cell-specific inactivation of the mouse Ipf1/Pdx-1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev., 12, 1763-1768.
32. McKinnon, C.M. and Doherty, K. (2001) Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. Diabetologia, 44, 1203-1214.
33. Ferrer, J. (2002) A genetic switch in pancreatic β-cells. Implications for differentiation and haploinsufficiency. Diabetes, 51, 2355-2362.
34. Lee, Y.H., Sauer, B. and Gonzalez, F.J. (1998) Laron dwarfism and non-insulin-dependent diabetes mellitus in the HNF-1alpha knockout mouse. Mol. Cell. Biol., 18, 3059-3068.
35. Pontoglio, M., Sreenan, S., Roe, M., Pugh, W., Ostrega, D., Doyen, A., Pick, A.J., Baldwin, A., Velho, G., Froguel, P. et al. (1998) Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. J. Clin. Invest., 101, 2215-2222.
36. Pearson, E.R., Starkey, B.J., Powell, R.J., Gribble, F.M., Clark, P.M. and Hattersley, A.T. (2003) Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet, 362, 1275-1281.
37. Hsueh, W.C., Mitchell, B.D., Aburomia, R., Pollin, T., Sakul, H., Gelder Ehm, M., Michelsen, B.K., Wagner, M.J., St Jean, P.L., Knowler, W.C. et al. (2000) Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care, 23, 595-601.
38. Lehtovirta, M., Kaprio, J., Forsblom, C., Eriksson, J., Tuomilehto, J. and Groop, L. (2000) Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins. Diabetologia, 43, 285-293.
39. Withers, D.J., Gutierrez, J.S., Towery, H., Burks, D.J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G.I. et al. (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature, 391, 900-904.
40. Ashcroft, F. and Rorsman, P. (2004) Type-2 diabetes mellitus: not quite exciting enough? Hum. Mol. Genet., 13, R21-R31.
41. Cardon, L.R. and Bell, J.I. (2001) Association study designs for complex diseases. Nat. Rev. Genet., 2, 91-99.
42. Risch, N. (2000) Searching for genetic determinants in the new millennium. Nature, 405, 847-856.
43. McCarthy, M.I., Smedley, D. and Hide, W. (2003) New methods for finding disease susceptibility genes: Impact and potential. Genome Biol., 4, 119.1-119.8.
44. Lohmueller, K.E., Pearce, C.L., Pike, M., Lander, E.S. and Hirschhorn, J.N. (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet., 33, 177-182.
45. Deeb, S.S., Fajas, L., Nemoto, M., Pihlajamaki, J., Mykkanen, L., Kuusisto, J., Laakso, M., Fujimoto, W. and Auwerx, J. (1998) A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet., 20, 284-287.
46. Altshuler, D., Hirschhorn, J.N., Klannemark, M., Lindgren, C.M., Vohl, M.C., Nemesh, J., Lane, C.R., Schaffner, S.F., Belk, S., Brewer, C. et al. (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet., 26, 76-80.
47. Douglas, J.A., Erdos, M.R., Watanabe, R.M., Braun, A., Johnston, C.L., Oeth, P., Mohlke, K.L., Valle, T.T., Ernholm, C., Buchanan, T.A. et al. (2001) The peroxisome proliferator-activated receptor-gamma2 Pro12Ala variant: Association with type 2 diabetes and trait differences. Diabetes, 50, 886-890.
48. Gloyn, A.L., Weedon, M.N., Owen, K.R., Turner, M.J., Knight, B.A., Hitman, G.A., Walker, M., Levy, J.C., Sampson, M.J., Halford, S. et al. (2003) Large scale association studies of variants in genes encoding the pancreatic beta-cell K-ATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with increased risk of Type 2 Diabetes. Diabetes, 52, 568-572.
49. Nielsen, E.D., Hansen, L., Carstensen, B., Echwald, S.M., Drivsholm, T., Glümer, C., Thorsteinsson, B., Borch-Johnsen, K., Hansen, T. and Pedersen, O. (2003) The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes, 52, 573-577.
50. Love-Gregory, L., Wasson, K., Lin, J., Skolnick, G., Suarez, B. and Permutt, M.A. (2002) An E23K single nucleotide polymorphism in the islet ATP-sensitive potassium channel gene (Kir6.2) contributes as much to the risk of type II diabetes in Caucasians as the PPARγ Pro12Ala variant. Diabetologia, 45, 136-137.
51. + channels. Diabetes, 51, 875-879.
52. Sakura, H., Wat, N., Horton, V., Millns, H., Turner, R.C. and Ashcroft, F.M. (1996) Sequence variations in the human Kir6.2 gene, a subunit of the beta-cell ATP-sensitive K-channel: No association with NIDDM in white Caucasian subjects or evidence of abnormal function when expressed in vitro. Diabetologia, 39, 1233-1236.
53. Jellema, A., Zeegers, M.P., Feskens, E.J., Dagnelie, P.C. and Mensink, R.P. (2003) Gly972Arg variant in the insulin receptor substrate-1 gene and association with type 2 diabetes: A metaanalysis of 27 studies. Diabetologia, 46, 990-995.
54. Barroso, I., Luan, J., Middelberg, R.P., Harding, A.H., Franks, P.W., Jakes, R.W., Clayton, D., Schafer, A.J., O'Rahilly, S. and Wareham, N.J. (2003) Candidate gene association study in Type 2 Diabetes indicates a role for genes involved in beta-cell function as well as insulin Action. PLoS Biol., 1, E20.
55. Huxtable, S.J., Saker, P.J., Haddad, L., Walker, M., Frayling, T.M., Levy, J.C., Hitman, G.A., O'Rahilly, S., Hattersley, A.T. and McCarthy, M.I. (2000) Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and type 2 diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat alleles. Diabetes, 49, 126-130.
56. Ek, J., Andersen, G., Urhammer, S.A., Gaede, P.H., Drivsholm, T., Borch-Johnsen, K., Hansen, T. and Pedersen, O. (2001) Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus. Diabetologia, 44, 2220-2226.
57. Triggs-Raine, B.L., Kirkpatrick, R.D., Kelly, S.L., Norquay, L.D., Cattini, P.A., Yamagata, K., Hanley, A.J., Zinman, B., Harris, S.B., Barrett, P.H. and Hegele, R.A. (2002) HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proc. Natl Acad. Sci. USA, 99, 4614-4619.
58. Mohlke, K.L., Silander, K., Peck, E.C., Scott, L.J., Hollstein, P.E., Skol, A.D., Li, C., Chimes, P.S., Watanabe, R.W., Boehnke, M. and Collins, F.S. (2003) Common non-coding SNPs near the Hepatocyte Nuclear Factor-4 Alpha gene are associated with type 2 diabetes. Am. J. Hum. Genet., 73, 210 (abstract).
59. Love-Gregory, L., Wasson, J., Ma, J., Jin, C.H., Suarez, B.K. and Permutt, M.A. (2003) A common polymorphism in the upstream promoter (P2) of the HNF4alpha gene on chromosome 20q is associated with type 2 diabetes (T2DM) and appears to account for the evidence for linkage in an Ashkenazi Jewish population. Am. J. Hum. Genet., 73, 534 (abstract).
60. Ghosh, S., Watanabe, R.M., Valle, T.T., Hauser, E.R., Magnuson, V.L., Langefeld, C.D., Ally, D.S., Mohlke, K.L., Silander, K., Kohtamaki, K. et al. (2000) The Finland-United States Investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am. J. Hum. Genet., 67, 1174-1185.
61. Permutt, M.A., Wasson, J.C., Suarez, B.K., Lin, J., Thomas, J., Meyer, J., Lewitzky, S., Ronnich, J.S., Parker, A., DuPrat, L. et al. (2001) A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population. Diabetes, 50, 681-685.
62. MacFarlane, W.M., Frayling, T.M., Ellard, S., Evans, J.C., Allen, L.I.S., Bulman, M.P., Ayres, S., Shepherd, M., Clark, P., Millward, A. et al. (1999) Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J. Clin. Invest., 104, R33-R39.
63. Weedon, M.N., Shields, B., Knight, B., Metcalf, B.S., Voss, L.D., Wilkin, T.J., Frayling, T.M. and Hattersley, A.T. (2003) A common variant in the glucokinase beta-cell gene promoter increases fasting glucose levels and is associated with altered birth weight. Diabetic Med., 20 (Suppl. 2), A44 (abstract).
64. Gabbay, K.H. (1980) The insulinopathies. New Engl. J. Med., 302, 165-167.
65. Barroso, I., Gurnell, M., Crowley, V.E., Agostini, M., Schwabe, J.W., Soos, M.A., Maslen, G.L., Williams, T.D., Lewis, H., Schafer, A.J. et al. (1999) Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature, 402, 880-883.
66. Longo, N., Wang, Y., Smith, S.A., Langley, S.D., DiMeglio, L.A. and Giannella-Neto, D. (2002) Genotype-phenotype correlation in inherited severe insulin resistance. Hum. Mol. Genet., 11, 1465-1475.
67. McCarthy, M.I. (2003) Growing evidence for diabetes susceptibility genes from genome scan data. Diabetes Curr. Rep., 3, 159-167.
68. McCarthy, M.I., Kruglyak, L. and Lander, E.S. (1998) Sib Pair collection strategies for complex diseases. Genet. Epidemiol., 15, 317-340.
69. Wiltshire, S., Hattersley, A.T., Hitman, G.A., Walker, M., Levy, J.C., Sampson, M., O'Rahilly, S., Frayling, T.M., Bell, J.I., Lathrop, G.M. et al. (2001) A genome-wide scan for loci predisposing to type 2 diabetes in a UK population (The Diabetes (UK) Warren 2 Repository): Analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am. J. Hum. Genet., 69, 553-569.
70. Kissebah, A.H., Sonnenberg, G.E., Myklebust, J., Goldstein, M., Broman, K., James, R.G., Marks, J.A., Krakower, G.R., Jacob, H.J., Weber, J. et al. (2002) Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc. Natl Acad. Sci. USA, 97, 14478-14483.
71. Mahtani, M.M., Widén, E., Lehto, M., Thomas, J., McCarthy, M., Brayer, J., Bryant, B., Chan, G., Daly, M., Forsblom, C. et al (1996) Mapping of a gene for NIDDM associated with an insulin secretion defect by a genome scan in Finnish families. Nat. Genet., 14, 90-95.
72. Hanson, R.L., Ehm, M.G., Pettitt, D.J., Prochazka, M., Thompson, D.B., Timberlake, D., Foroud, T., Kobes, S., Baier, L., Burns, D.K. et al. (1998) An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am. J. Hum. Genet., 63, 1124-1132.
73. Elbein, S.C., Hoffman, M.D., Teng, K., Leppert, M.F. and Hasstedt, S.J. (1999) A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes, 48, 1175-1182.
74. Hsueh, W.C., St Jean, P.L., Mitchell, B.D., Pollin, T.I., Knowler, W.C., Ehm, M.G., Bell, C.J., Sakul, H., Wagner, M.J., Burns, D.K. and Shuldiner, A.R. (2003) Genome-wide and fine-mapping linkage studies of type 2 diabetes and glucose traits in the Old Order Amish: evidence for a new diabetes locus on chromosome 14q11 and confirmation of a locus on chromosome 1q21-q24. Diabetes, 52, 550-557.
75. Meigs, J.B., Panhuysen, C.I., Myers, R.H., Wilson, P.W. and Cupples, L.A. (2002) A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study. Diabetes, 51, 833-840.
76. Vionnet, N., Hani, E.H., Dupont, S., Gallina, S., Francke, S., Dotte, S., De Matos, F., Durand, E., Lepêtre, F., Lecouer, C. et al. (2000) Genomewide search for type 2 diabetes-susceptibility genes in French Whites: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am. J. Hum. Genet., 67, 1470-1480.
77. Xiang, K., Wang, Y., Zheng, T., Jia, W., Li, J., Chen, L., Shen, K., Wu, S., Lin, X., Zhang, G. et al. (2004) Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: Significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes 53, 228-234.
78. Ng, N.C.Y., So, W.-Y., Lam, V.K.L., Cockram, C.S. and Chan, J.C.N. (2003) Identification of a susceptibility locus on chromosome 1q for metabolic syndrome traits in Hong Kong Chinese diabetic families. Diabetes, 52 (Suppl. 2), 150-OR (abstract).
79. Hegele, R.A., Anderson, C.M. and Cao, H. (2000) Lamin A/C mutation in a woman and her two daughters with Dunnigan-type partial lipodystrophy and insulin resistance Diabetes Care, 23, 258-259.
80. Hirayama, I., Tamemoto, H., Yokota, H., Kubo, S.K., Wang, J., Kuwano, H., Nagamachi, Y., Takeuchi, T. and Izumi, T. (1999) Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2. Diabetes, 48, 1237-1244.
81. Oliphant, A., Barker, D.L., Stuelpnagel, J.R. and Chee, M.S. (2002) BeadArray technology: Enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques (suppl.), 56-58.
82. Gabriel, S.B., Schaffner, S.F., Nguyen, H., Moore, J.M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M. et al. (2002) The structure of haplotype blocks in the human genome. Science, 296, 2225-2229.
83. Horikawa, Y., Oda, N., Cox, N.J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T.M., Mashima, H., Schwarz, P.E.H. et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet., 26, 163-175.
84. Hanis, C.L., Boerwinkle, E., Chakraborty, R., Ellsworth, D.L., Concannon, P., Stirling, B., Morrison, V.A., Wapelhorst, B., Spielman, R.S., Gogolin-Ewens, K.J. et al. (1996) A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat. Genet., 13, 161-171.
85. Evans, J.C., Frayling, T.M., Cassell, P.G., Saker, P.J., Hitman, G.A., Walker, M., Levy, J.C., O'Rahilly, S., Subba Rao, P.V., Bennett, A.J. et al. (2001) Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am. J. Hum. Genet., 69, 544-552.
86. Weedon, M.N., Schwarz, P.E.H., Horikawa, Y., Iwasaki, N., Illig, T., Holle, R., Rathmann, W., Selisko, T., Schulze, J., Owen, K.R. et al. (2003) Meta-analysis confirms a role for calpain-10 variation in type 2 diabetes susceptibility. Am. J. Hum. Genet., 73, 1208-1212.
87. Zhou, Y.P., Sreenan, S., Pan, C.Y., Currie, K.P., Bindokas, V.P., Horikawa, Y., Lee, J.P., Ostrega, D., Ahmed, N., Baldwin, A.C. et al. (2003) A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin. Metabolism, 52, 528-534.
88. Reifsnyder, P.C. and Leiter, E.H. (2002) Deconstructing and reconstructing obesity-induced diabetes (diabesity) in mice. Diabetes, 51, 825-832.
89. Fakhrai-Rad, H., Nikoshkov, A., Kamel, A., Fernström, M., Zierath, J.R., Norgren, S., Luthman, H. and Galli, J. (2000) Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. Hum. Mol. Genet., 9, 2149-2158.
90. Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E.A., Frosch, M.P., Eckman, C.B., Tanzi, R.E., Selkoe, D.J. and Guénette, S. (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo. Proc. Natl Acad. Sci. USA, 100, 4162-4167.
91. Groves, C.J., Wiltshire, S., Smedley, D., Owen, K.R., Frayling, T.M., Walker, M., Hitman, G.A., Levy, J.C., O'Rahilly, S., Menzel, S. et al. (2003) Association and haplotype analysis of the Insulin Degrading Enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility. Diabetes, 52, 1300-1305.
92. Karamohamed, S., Demissie, S., Volcjak, J., Liu, C., Heard-Costa, N., Liu, J., Shoemaker, C.M., Panhuysen, C.I., Meigs, J.B., Wilson, P. et al. (2003) NHLBI Framingham Heart Study. Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. Diabetes, 52, 1562-1567.
93. Aulchenko, Y.S., Vaessen, N., Heutink, P., Pullen, J., Snijders, P.J., Hofman, A., Sandkuijl, L.A., Houwing-Duistermaat, J.J., Edwards, M., Bennett, S. et al. (2003) A genome-wide search for genes involved in type 2 diabetes in a recently genetically isolated population from the Netherlands. Diabetes, 52, 3001-3004.
94. Maeda, S., Kanazawa, A., Tsukada, S., Kashiwagi, A., Haneda, M., Kikkawa, R. and Nakamura, Y. (2003) Genome-wide analysis of single nucleotide polymorphism to search the susceptibility gene(s) for type 2 diabetes. Diabetes, 52 (Suppl. 2), 149-OR (abstract).
95. Mootha, V.K., Lindgren, C.M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstrå le, M., Laurila, E. et al. (2003) PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet., 34, 267-273.
96. Patti, M.E., Butte, A.J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R. et al. (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl Acad. Sci. USA, 100, 8466-8471.
97. Risch, N. and Merikangas, K. (1996) The future of genetic studies of complex human diseases. Science, 273, 1516-1517.
98. Yang, W.Y.S., Cordell, H.A. and Todd, J.A. (2003) Association mapping of complex diseases in linked regions: Estimation of genetic effects and feasibility of testing rare variants. Genet. Epidemiol., 24, 36-43.
99. Risch, N. and Teng, J. (1998) The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases. I. DNA pooling. Genome Res., 8, 1273-1288.
100. Frayling, T.M., Wiltshire, S., Hitman, G.A., Walker, M., Levy, J.C., Sampson, M., Groves, C.J., Menzel, S., McCarthy, M.I. and Hattersley, A.T. (2003) Young-onset type 2 diabetes families are the major contributors to genetic loci in the Diabetes UK Warren 2 genome scan and identify putative novel loci on chromosomes 8q21, 21q22 and 22q11. Diabetes, 57, 1857-1863.
101. Cordell, H.J. and Clayton, D.G. (2002) A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: Application to HLA in type 1 diabetes. Am. J. Hum. Genet., 70, 124-141.
102. Loots, G.G., Ovcharenko, I., Pachter, L., Dubchak, I. and Rubin, E.M. (2002) rVISTA for comparative sequence-based discovery of functional transcription factor binding sites. Genome Res., 12, 832-839.
103. Moller, D.E. (2001) New drug targets for type 2 diabetes and the metabolic syndrome. Nature, 414, 821-827.
104. Haga, S.B., Khoury, M.J. and Burke, W. (2003) Genomic profiling to promote a healthy lifestyle: Not ready for prime time. Nat. Genet., 34, 347-350.
105. Pharoah, P.D., Antoniou, A., Bobrow, M., Zimmern, R.L., Easton, D.F. and Ponder, B.A. (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet., 31, 33-36.
106. Yang, Q., Khoury, M.J., Botto, L., Friedman, J.M. and Flanders, W.D. (2003). Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am. J. Hum. Genet., 72, 636-649.
107. Diaz, G.A., Banikazemi, M., Oishi, K., Desnick, R.J. and Gelb, B.D. (1999) Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome. Nat. Genet., 22, 309-312.
108. Fleming, J.C., Tartaglini, E., Steinkamp, M.P., Schorderet, D.F., Cohen, N. and Neufeld, E.J. (1999) The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter. Nat. Genet., 22, 305-308.
109. Labay, V., Raz, T., Baron, D., Mandel, H., Williams, H., Barrett, T., Szargel, R., McDonald, L., Shalata, A., Nosaka, K. et al. (1999) Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nat. Genet., 22, 300-304.
110. Collin, G.B., Marshall, J.D., Ikeda, A., So, W.V., Russell-Eggitt, I., Maffei, P., Beck, S., Boerkoel, C.F., Sicolo, N., Martin, M. et al. (2002) Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome. Nat. Genet., 31, 74-78.
111. Hearn, T., Renforth, G.L., Spalluto, C., Hanley, N.A., Piper, K., Brickwood, S., White, C., Connolly, V., Taylor, J.F., Russell-Eggitt, I. et al. (2002) Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alstrom syndrome. Nat. Genet., 31, 79-83.
112. Yoshida, K., Furihata, K., Takeda, S., Nakamura, A., Yamamoto, K., Morita, H., Hiyamuta, S., Ikeda, S., Shimizu, N. and Yanagisawa, N. (1995) A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat. Genet., 9, 267-272.
113. Inoue, H., Tanizawa, Y., Wasson, J., Behn, P., Kalidas, K., Bernal-Mizrachi, E., Mueckler, M., Marshall, H., Donis-Keller, H., Crock, P. et al. (1998) A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat. Genet., 20, 143-148.
114. O'Rahilly, S., Gray, H., Humphreys, P.J., Krook, A., Polonsky, K.S., White, A., Gibson, S., Taylor, K. and Carr, C. (1995) Brief report: Impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. New Engl. J. Med., 333, 1386-1390.
115. Hanson, E.H., Imperatore, G. and Burke, W. (2001) HFE gene and hereditary hemochromatosis: A HuGE review. Human Genome Epidemiology. Am. J. Epidemiol., 154, 193-206.
116. Arima, T., Drewell, R.A., Arney, K.L., Inoue, J., Makita, Y., Hata, A., Oshimura, M., Wake, N. and Surani, M.A. (2001) A conserved imprinting control region at the HYMAI/ZAC domain is implicated in transient neonatal diabetes mellitus. Hum. Mol. Genet., 10, 1475-1483.
117. Campuzano, V., Montermini, L., Molto, M.D., Pianese, L., Cossee, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A. et al. (1996) Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science, 271, 1423-1427.
118. Agarwal, A.K., Arioglu, E., De Almeida, S., Akkoc, N., Taylor, S.I., Bowcock, A.M., Barnes, R.I. and Garg, A. (2002) AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat. Genet., 31, 21-23.
119. Magre, J., Delepine, M., Khallouf, E., Gedde-Dahl, T. Jr., Van Maldergem, L., Sobel, E., Papp, J., Meier, M., Megarbane, A., Bachy, A. et al. (2002) Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat. Genet., 28, 365-370.
120. Kadowaki, T., Kadowaki, H., Mori, Y., Tobe, K., Sakuta, R., Suzuki, Y., Tanabe, Y., Sakura, H., Awata, T., Goto, Y. et al. (1994) A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. New Engl. J. Med., 330, 962-968.
121. Minton, J., Hattersley, A.T., Owen, K.R., McCarthy, M.I., Walker, M., Barrett, T. and Frayling, T.M. (2002) Association studies of genetic variation in the WFS1 gene and type 2 diabetes in UK populations. Diabetes, 51, 1287-1290.
122. Moczulski, D.K., Grzeszczak, W. and Gawlik, B. (2001) Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy. Diabetes Care, 24, 1187-1191.
123. Halsall, D.J., McFarlane, I., Luan, J., Cox, T.M. and Wareham, N.J. (2003) Typical type 2 diabetes mellitus and HFE gene mutations: A population-based case-control study. Hum. Mol. Genet., 12, 1361-1365.
124. t'Hart, L.M., Stolk, R.P., Heine, R.J., Grobbee, D.E., van der Does, F.E. and Maassen, J.A. (1996) Association of the insulin-receptor variant Met-985 with hyperglycemia and non-insulin-dependent diabetes mellitus in the Netherlands: A population-based study. Am. J. Hum. Genet., 59, 1119-1122.